Appropriate Use of Non-steroidal Anti-inflammatory Drugs in Rheumatology: Guidelines From the Spanish Society of Rheumatology and the Mexican College of Rheumatology

Fosbol EL, Gislason GH, Jacobsen S, Abildstrom SZ, Hansen ML, Schramm TK, et al. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people. Pharmacoepidemiol Drug Saf. 2008. [journal on-line; cited July 1, 2008]. Available from: http://www3. interscience.wiley.com/journal/5669/home. Ballina, 2002, Impacto del consumo de AINE en la población general española: Resultados del estudio EPISER, Rev Esp Reumatol, 29, 337 Grupos terapéuticos y principios activos de mayor consumo por el Sistema Nacional de Salud durante 2004. Informe Farmacoterapéutico del Sistema Nacional de Salud. 2005;28:121-4. Pincus, 2005, Patient preference in a crossover clinical trial of patients with osteoarthritis of the knee or hip: face validity of selfreport questionnaire ratings, J Rheumatol, 32, 533 Rainsford, 2007, Anti-inflammatory drugs in the 21st century, Subcell Biochem, 42, 3, 10.1007/1-4020-5688-5_1 Strand, 2007, Are COX-2 inhibitors preferable to non-selective non-steroidal antiinflammatory drugs in patients with risk of cardiovascular events taking low-dose aspirin?, Lancet, 370, 2138, 10.1016/S0140-6736(07)61909-6 Chen, 2008, Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation, Health Technol Assess, 12, 1, 10.3310/hta12110 Winzeler, 1998, Non-steroidal antiinflammatory drugs. A review, AAOHN J, 46, 253, 10.1177/216507999804600505 Curry, 2005, Nonsteroidal antiinflammatory drugs: a review, J Am Anim Hosp Assoc, 41, 298, 10.5326/0410298 Kearney, 2006, Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials, BMJ, 332, 1302, 10.1136/bmj.332.7553.1302 Schaffer, 2006, Risk of serious NSAID-related gastrointestinal events during long-term exposure: a systematic review, Med J Aust, 185, 501, 10.5694/j.1326-5377.2006.tb00665.x Antman, 2007, Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association, Circulation, 115, 1634, 10.1161/CIRCULATIONAHA.106.181424 Szmitko, 2007, Review: nonselective nonsteroidal antiinflammatory drugs do not increase risk for cardiovascular events, ACP J Club, 146, 12, 10.7326/ACPJC-2007-146-1-012 Fitch, 2001 Center for Evidence Based Medicine. Levels of evidence. 2008 [cited April 8, 2008]. Available from: http://www.cebm.net/index.aspx?o=1025 Roberts, 2001, Analgesic, antipyretic and anti-inflammatory agents and drugs used for the treatment of gout, 669 Alonso, 2001, Concepto y clasificación de las enfermedades reumáticas Loza, 2008, Revisión sistemática: ¿hay alguna razón para contraindicar el uso concomitante de antiinflamatorios no esteroideos y esteroides?, Reumatol Clin, 4, 220, 10.1016/S1699-258X(08)75542-6 Pocock, 2001, A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials, BMJ, 323, 75, 10.1136/bmj.323.7304.75 Bennett M. A risk score for cardiovascular disease. 2005 [cited May 12, 2008]. Available from: http://www.riskscore.org.uk/ Grau, 2008, Funciones de riesgo en la prevención primaria de las enfermedades cardiovasculares, Rev Esp Cardiol, 61, 404, 10.1157/13117732 Horackova, 2004, Life-threatening renal failure caused by vasomotor nephropathy associated with nonsteroidal anti-inflammatory drugs, Int J Clin Pharmacol Res, 24, 117 Pincus, 1993, Variability in individual responses of 532 patients with rheumatoid arthritis to first-line and second-line drugs, Agents Actions Suppl, 44, 67 Sánchez Gómez LM. Eficacia y seguridad de los antiinflamatorios no esteroideos en pacientes menores de 18 años con dolor de origen músculo-esquelético [cited January 1, 2008]. Reumatología basada en la evidencia. Available from: http://www.ser.es/ArchivosDESCARGABLES/consensos/RevAINEsninios.pdf. Loza, 2008, Revisión sistemática: ¿es eficaz y seguro el uso de AINE para los ancianos?, Reumatol Clin, 4, 172, 10.1016/S1699-258X(08)72461-6 Gibofsky, 2003, Comparing the efficacy of cyclooxygenase 2-specific inhibitors in treating osteoarthritis: appropriate trial design considerations and results of a randomized, placebo-controlled trial, Artritis Rheum, 48, 3102, 10.1002/art.11330 Cheng, 2004, A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis, Clin Ther, 26, 399, 10.1016/S0149-2918(04)90035-5 Boulos, 2005, Pharmacological treatment of ankylosing spondylitis: a systematic review, Drugs, 65, 2111, 10.2165/00003495-200565150-00004 Bjordal, 2007, Short-term efficacy of pharmacotherapeutic interventions in osteoarthritic knee pain: A meta-analysis of randomised placebo-controlled trials, Eur J Pain, 11, 125, 10.1016/j.ejpain.2006.02.013 Cepeda, 2006, Tramadol for osteoarthritis, Cochrane Database Syst Rev, 3, 10.1002/14651858.CD005522.pub2 Bellamy, 2006, Intraarticular corticosteroid for treatment of osteoarthritis of the knee, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD005328.pub2 Bellamy, 2006, Viscosupplementation for the treatment of osteoarthritis of the knee, Cochrane Database Syst Rev, 2, 10.1002/14651858.CD005328.pub2 Loza, 2008, Revisión sistemática sobre la seguridad del uso concomitante de fármacos hipoglucemiantes y antiinflamatorios no esteroideos en pacientes con enfermedad reumática, Reumatol clin, 4, 232, 10.1016/S1699-258X(08)75544-X Smith, 2006, AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update: endorsed by the National Heart, Lung, and Blood Institute, Circulation, 113, 2363, 10.1161/CIRCULATIONAHA.106.174516 Bombardier, 2000, Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis, N Engl J Med, 343, 1520, 10.1056/NEJM200011233432103 Loza, 2008, Revisión sistemática sobre la seguridad del uso concomitante de fármacos hipoglucemiantes y antiinflamatorios no esteroideos en pacientes con enfermedad reumática, Reumatol clin, 4, 232, 10.1016/S1699-258X(08)75544-X Delaney, 2007, Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding, CMAJ, 177, 347, 10.1503/cmaj.070186 Knijff-Dutmer, 2003, Concomitant coumarin-NSAID therapy and risk for bleeding, Ann Pharmacother, 37, 12, 10.1345/aph.1C157 Knijff-Dutmer, 2003, The influence of cyclooxygenase specificity of non-steroidal anti-inflammatory drugs on bleeding complications in concomitant coumarine users, QJM, 96, 513, 10.1093/qjmed/hcg090 Hilleman, 1993, Nonsteroidal antiinflammatory drug use in patients receiving warfarin: emphasis on nabumetone, Am J Med, 95, S30, 10.1016/0002-9343(93)90394-5 Nishishinya B, Loza E. Revisión sistemática: ¿qué AINE presenta un menor riesgo de toxicidad renal? [cited January 1, 2008]. Reumatología basada en la evidencia. Available from: http://www.ser.es/ArchivosDESCARGABLES/consensos/RevAINEstoxrenal. pdf. Hidalgo Natera, 2004, Meningitis aséptica probablemente inducida por ibuprofeno en una paciente con lupus eritematoso sistémico, Med Clin (Barc), 122, 678, 10.1157/13061396 Martínez López, 2008, Revisión sistemática: ¿es seguro el uso de AINE durante el embarazo?, Reumatol Clin, 4, 191, 10.1016/S1699-258X(08)72463-X